However, a recent study found that netropsin was not selectively cytocidal to only HMGA2-overexpressing colorectal cancer cells [193], and its potential binding to other AT-hook DNA domains might introduce off-target side-effects, making it therapeutically inefficient. The gene discussed is HMGA2; the disease is colorectal cancer.